title: PARP inhibitors target ATM+p53-defective gastric cancer.
authors.affiliation: a Newcastle University; Northern Institute for Cancer Research; Medical School ; Newcastle-upon-Tyne , UK ; Email: nicola.curtin@ncl.ac.uk.
authors.forename: Nicola J
authors.initials: NJ
authors.lastname: Curtin
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D064007:Ataxia Telangiectasia Mutated Proteins / Q000235:genetics*; D006801:Humans; D010793:Phthalazines / Q000494:pharmacology*; D010879:Piperazines / Q000494:pharmacology*; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D013274:Stomach Neoplasms / Q000473:pathology*; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D010793:Phthalazines; D010879:Piperazines; D000067856:Poly(ADP-ribose) Polymerase Inhibitors; D016159:Tumor Suppressor Protein p53; D064007:Ataxia Telangiectasia Mutated Proteins